Cover Image
市場調查報告書

轉移性大腸癌:全球臨床實驗趨勢

Metastatic Colorectal Cancer Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 602476
出版日期 內容資訊 英文 1293 Pages
訂單完成後即時交付
價格
Back to Top
轉移性大腸癌:全球臨床實驗趨勢 Metastatic Colorectal Cancer Global Clinical Trials Review, H2, 2017
出版日期: 2017年12月28日 內容資訊: 英文 1293 Pages
簡介

本報告提供轉移性大腸癌治療藥臨床實驗相關的基本數據和資料,彙整實驗數量及受驗者的募集情況,各階段趨勢,實施臨床實驗的主要製藥企業及研究機關的簡介等資料。

本報告概要

調查範圍

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5國的臨床實驗數量
    • 中南美主要5國的臨床實驗數量

G7各國臨床實驗數量:癌症治療藥臨床實驗上轉移性大腸癌的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:癌症治療藥臨床實驗上轉移性大腸癌的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

轉移性大腸癌治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介概要

附錄

目錄
Product Code: GDHC4782CTIDB

GlobalData's clinical trial report, "Metastatic Colorectal Cancer Global Clinical Trials Review, H2, 2017" provides an overview of Metastatic Colorectal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Colorectal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials 19
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Metastatic Colorectal Cancer Therapeutics Clinical Trials 29
  • Prominent Drugs 30
  • Latest Clinical Trials News on Metastatic Colorectal Cancer 31
  • Dec 17, 2017: JHL Submits Clinical Trial Application for Proposed Bevacizumab Biosimilar 31
  • Dec 01, 2017: First patient included in Phase I study aiming at supporting expansion of global Phase III program for PledOx to include Asian patients 31
  • Nov 28, 2017: MOLOGEN to Present Poster on Lefitolimod at ESMO IO 2017 31
  • Nov 18, 2017: Study Shows New Second Line Therapy for Metastatic Colorectal Cancer is Effective and Safe 31
  • Oct 09, 2017: First patient treated with microscopic beads pre-loaded with a targeted cancer drug and visible on CT scans 32
  • Oct 04, 2017: eFFECTOR Therapeutics Initiates Dosing in Phase 2 Combination Trial of eFT508 and Avelumab in Microsatellite Stable Colorectal Cancer 33
  • Oct 03, 2017: NOXXON Publishes Preclinical Proof-of-Concept Data for Lead Compound NOX-A12 in Combination with Checkpoint Inhibitors 34
  • Sep 27, 2017: Aduro Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Personalized Immunotherapy pLADD Based on Proprietary Neoantigen Technology 34
  • Clinical Trial Profile Snapshots 35
  • Appendix 1290
  • Abbreviations 1290
  • Definitions 1290
  • Research Methodology 1291
  • Secondary Research 1291
  • About GlobalData 1292
  • Contact Us 1292
  • Disclaimer 1292
  • Source 1293

List of Tables

  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 8
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
  • Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 16
  • Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Metastatic Colorectal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Metastatic Colorectal Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 19
  • Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Metastatic Colorectal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
  • Metastatic Colorectal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Metastatic Colorectal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
  • Metastatic Colorectal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
Back to Top